<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04052373</url>
  </required_header>
  <id_info>
    <org_study_id>IMPLANTOPLASTY</org_study_id>
    <nct_id>NCT04052373</nct_id>
  </id_info>
  <brief_title>Peri-implantitis Implantoplasty Treatment</brief_title>
  <official_title>Surgical Peri-implantitis Treatment With and Without Implantoplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oslo</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This double arm, split-mouth, single centre, controlled, randomised clinical study is
      designed to examine the effect of implantoplasty in treatment of peri-implantitis.

      Peri-implantitis will be treated with open flap debridement, with or without implantoplasty.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2019</start_date>
  <completion_date type="Anticipated">June 15, 2027</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Measured with a periodontal probe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>24 months after treatment</time_frame>
    <description>Measured with a periodontal probe</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Suppuration</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Visible suppuration upon probing the implant with a periodontal probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suppuration</measure>
    <time_frame>24 months after treatment</time_frame>
    <description>Visible suppuration upon probing the implant with a periodontal probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pocket probing depth</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Measured with a periodontal probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pocket probing depth</measure>
    <time_frame>24 months after treatment</time_frame>
    <description>Measured with a periodontal probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in patient-reported quality of life (QoL)</measure>
    <time_frame>Preoperatively compared to 24 months after treatment</time_frame>
    <description>To assess QoL changes related to mouth and teeth prior to therapy to after therapy by the use of &quot;The Oral Impacts on Daily Performance (OIDP)&quot; instrument. Each question is assessed by a 5-point scale; (1) never affected; (2) less than once a month; (3) once or twice a month; (4) once or twice a week; and (5) every or nearly every day. The higher number represents more severe impact on quality of life; e.g. worse outcome.
Each item will be dichotomised yielding the categories (A) affected; including scale categories (2)-(5), and (B) unaffected; including category (1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment loss measurements</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Measured with a periodontal probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment loss measurements</measure>
    <time_frame>24 months after treatment</time_frame>
    <description>Measured with a periodontal probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic bone loss</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Measured on standardized radiograps</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic bone loss</measure>
    <time_frame>24 months after treatment</time_frame>
    <description>Measured on standardized radiograps</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant fracture</measure>
    <time_frame>24 months</time_frame>
    <description>Clinical examination to assess whether implants have fractured following treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Peri-Implantitis</condition>
  <condition>Peri-implant Mucositis</condition>
  <arm_group>
    <arm_group_label>Peri-implantitis treatment with implantoplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open flap debridement with implantoplasty treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peri-implantitis treatment without implantoplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open flap debridement withput implantoplasty treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Implantoplasty</intervention_name>
    <description>Implantoplasty is the mechanical smoothening of rough titanium implants as part of the surgical treatment of peri-implantitis. Treatment is thought to facilitate self-performed oral hygiene.</description>
    <arm_group_label>Peri-implantitis treatment with implantoplasty</arm_group_label>
    <arm_group_label>Peri-implantitis treatment without implantoplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open flap debridement alone</intervention_name>
    <description>Open flap debridement alone</description>
    <arm_group_label>Peri-implantitis treatment with implantoplasty</arm_group_label>
    <arm_group_label>Peri-implantitis treatment without implantoplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Peri-implantitis (according to 2018 criteria) on minimum 2 implants of similar surface
             and defect type

          -  Competent to give consent

          -  Exposed, modified implant surface with loss &gt;2mm

        Exclusion Criteria:

          -  Previous radiotherapy to the jaws, current use of chemotherapy, systemic long-term
             corticosteroid treatment

          -  Present or past use of bisphosphonate treatment â€¢ Pregnant or nursing subjects

          -  Patients classified as &gt; class II according to ASA classification

          -  Implant unavailable for implantoplasty treatment

          -  Inhability to comprehend and respond to the quality of life questionnaire

          -  Examiners/operators deem original placement of implant (angle, position) suboptimal
             and considered to play a major role in development of peri-implantitis

          -  History of peri-implantitis surgery prior to 6 months of screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo</name>
      <address>
        <city>Oslo</city>
        <zip>0455</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anders Verket, PhD</last_name>
      <phone>+47 93667661</phone>
      <email>anderver@odont.uio.no</email>
    </contact>
    <contact_backup>
      <last_name>Odd Koldsland, PhD</last_name>
      <phone>+47 93098618</phone>
      <email>oddcko@odont.uio.no</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Institute of Clinical Dentistry, University of Oslo, Norway</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anders Verket, PhD</last_name>
      <phone>+47 22852064</phone>
      <email>anderver@odont.uio.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 6, 2019</study_first_submitted>
  <study_first_submitted_qc>August 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2019</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oslo</investigator_affiliation>
    <investigator_full_name>Anders Verket</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucositis</mesh_term>
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

